Illumina 2025-12-16 Cell Free DNA Testing Market Is Going to Boom |• Illumina • Guardant Health - openPR.com
eLife 2025-12-16 A systematic bi-genomic split-GFP assay illuminates the mitochondrial matrix proteome and protein targeting routes
Illumina 2025-12-15 Illumina (NASDAQ:ILMN) Given New $130.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Illumina 2025-12-15 Twists, tangles, and transcription: Does epigenetics play a role in Alzheimer's? - Illumina
Illumina 2025-12-15 Marex Group plc Makes New $1.24 Million Investment in Illumina, Inc. $ILMN - MarketBeat
10x Genomics Blog 2025-12-15 Spatial Transcriptomics Market Is Going to Boom |• 10X Genomics • Illumina - openPR.com
Illumina 2025-12-14 Illumina’s AI Genomics Partnership With MyOme Might Change The Case For Investing In Illumina (ILMN) - simplywall.st
Illumina 2025-12-14 Nikko Asset Management Americas Inc. Increases Stake in Illumina, Inc. $ILMN - MarketBeat
Illumina 2025-12-11 Your lab’s new best friend for scalable proteomics: Illumina Protein Prep - Illumina
Illumina 2025-12-11 Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually - marketscreener.com
Illumina 2025-12-11 Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually | Newswise - Newswise
Illumina 2025-12-11 Illumina (NASDAQ: ILMN) invests in MyOme to launch AI-driven WGS trial in 2026 - Stock Titan
Illumina 2025-12-11 Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually - PR Newswire
Illumina 2025-12-10 Stifel reiterates Buy rating on Illumina stock, cites multiple growth levers - Investing.com UK